{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:07:48Z","timestamp":1774998468180,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T00:00:00Z","timestamp":1505088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.clinthera.2017.08.021","type":"journal-article","created":{"date-parts":[[2017,12,2]],"date-time":"2017-12-02T00:00:26Z","timestamp":1512172826000},"page":"64-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effects of Flibanserin on the Pharmacokinetics of a Combined Ethinylestradiol\/Levonorgestrel Oral Contraceptive in Healthy Premenopausal Women: A Randomized Crossover Study"],"prefix":"10.1016","volume":"40","author":[{"given":"Crista","family":"Johnson-Agbakwu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Kissling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Greenblatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2017.08.021_bib1","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1743-6109.2009.01309.x","article-title":"Pathways of sexual desire","volume":"6","author":"Pfaus","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/j.clinthera.2017.08.021_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1743-6109.2010.02032.x","article-title":"Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder","volume":"8","author":"Stahl","year":"2011","journal-title":"J Sex Med"},{"key":"10.1016\/j.clinthera.2017.08.021_bib3","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1743-6109.2007.00768.x","article-title":"What is the \"true\" prevalence of female sexual dysfunctions and does the way we assess these conditions have an impact?","volume":"5","author":"Hayes","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.clinthera.2017.08.021_bib4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/jwh.2011.3002","article-title":"Sexual desire problems in women seeking healthcare: a novel study design for ascertaining prevalence of hypoactive sexual desire disorder in clinic-based samples of U.S. women","volume":"21","author":"Rosen","year":"2012","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.clinthera.2017.08.021_bib5","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s40263-015-0288-1","article-title":"The female sexual response: current models, neurobiological underpinnings and agents currently approved or under investigation for the treatment of hypoactive sexual desire disorder","volume":"29","author":"Kingsberg","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.clinthera.2017.08.021_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1527-3458.2002.tb00219.x","article-title":"Pharmacology of flibanserin","volume":"8","author":"Borsini","year":"2002","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.clinthera.2017.08.021_bib7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1017\/S1461145702002869","article-title":"Region-dependent effects of flibanserin and buspirone on adenylyl cyclase activity in the human brain","volume":"5","author":"Marazziti","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.clinthera.2017.08.021_bib8","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1111\/jsm.12189","article-title":"Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial","volume":"10","author":"Katz","year":"2013","journal-title":"J Sex Med"},{"key":"10.1016\/j.clinthera.2017.08.021_bib9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1743-6109.2011.02595.x","article-title":"Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study","volume":"9","author":"Thorp","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.clinthera.2017.08.021_bib10","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1743-6109.2011.02626.x","article-title":"Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study","volume":"9","author":"Derogatis","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.clinthera.2017.08.021_bib11","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/GME.0000000000000134","article-title":"Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial","volume":"21","author":"Simon","year":"2014","journal-title":"Menopause"},{"key":"10.1016\/j.clinthera.2017.08.021_bib12","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1111\/j.1743-6109.2012.02942.x","article-title":"Open-label extension study of flibanserin in women with hypoactive sexual desire disorder","volume":"9","author":"Jayne","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.clinthera.2017.08.021_bib13","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1111\/j.1743-6109.2011.02458.x","article-title":"Continued efficacy and safety of flibanserin in premenopausal women with hypoactive sexual desire disorder (HSDD): results from a randomized withdrawal trial","volume":"8","author":"Goldfischer","year":"2011","journal-title":"J Sex Med"},{"key":"10.1016\/j.clinthera.2017.08.021_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1056\/NEJMp1513686","article-title":"FDA approval of flibanserin\u2014treating hypoactive sexual desire disorder","volume":"374","author":"Joffe","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2017.08.021_bib15","doi-asserted-by":"crossref","first-page":"472","DOI":"10.2165\/00003088-199018060-00004","article-title":"Pharmacokinetic drug interactions with oral contraceptives","volume":"18","author":"Back","year":"1990","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2017.08.021_bib16","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/aji.12210","article-title":"Effects of hormonal contraception on antiretroviral drug metabolism, pharmacokinetics and pharmacodynamics","volume":"71","author":"Thurman","year":"2014","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.clinthera.2017.08.021_bib17","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.clpt.2003.08.009","article-title":"The interaction between St John's wort and an oral contraceptive","volume":"74","author":"Hall","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2017.08.021_bib18","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1365-2125.1990.tb05457.x","article-title":"The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids","volume":"30","author":"Crawford","year":"1990","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2017.08.021_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2125.2005.02539.x","article-title":"The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects","volume":"61","author":"Sidhu","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2017.08.021_bib20","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1124\/dmd.104.000182","article-title":"The involvement of CYP3A4 and CYP2C9 in the metabolism of 17\u03b1-ethinylestradiol","volume":"32","author":"Wang","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.clinthera.2017.08.021_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/00003088-200746020-00003","article-title":"Pharmacokinetic drug interactions involving 17\u03b1ap-ethinylestradiol: a new look at an old drug","volume":"46","author":"Zhang","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2017.08.021_bib22","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1248\/bpb.27.1900","article-title":"Interindividual variability in 2-hydroxylation, 3-sulfation, and 3-glucuronidation of ethynylestradiol in human liver","volume":"27","author":"Shiraga","year":"2004","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.clinthera.2017.08.021_bib23","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1046\/j.1365-2125.1999.00081.x","article-title":"Effects of cytochrome P450 inducers on 17\u03b1-ethinyloestradiol (EE2) conjugation by primary human hepatocytes","volume":"48","author":"Li","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2017.08.021_bib24","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/bcp.12668","article-title":"Ritonavir is the best alternative to ketoconazole as an index inhibitor of cytochrome P450-3A in drug-drug interaction studies","volume":"80","author":"Greenblatt","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2017.08.021_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2125.1998.00749.x","article-title":"Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers","volume":"46","author":"Ouellet","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2017.08.021_bib26","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0009-9236(99)70138-4","article-title":"The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive","volume":"65","author":"Barditch-Crovo","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2017.08.021_bib27","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1111\/j.1743-6109.2012.02848.x","article-title":"The effects of hormonal contraceptives on female sexuality: a review","volume":"9","author":"Burrows","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.clinthera.2017.08.021_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/13625187.2012.728643","article-title":"The influence of combined oral contraceptives on female sexual desire: a systematic review","volume":"18","author":"Pastor","year":"2013","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.clinthera.2017.08.021_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0010-7824(01)00218-9","article-title":"A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation","volume":"64","author":"Sanders","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.clinthera.2017.08.021_bib30","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1111\/j.1743-6109.2010.01742.x","article-title":"Prevalence of sexual dysfunction and impact of contraception in female German medical students","volume":"7","author":"Wallwiener","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.clinthera.2017.08.021_bib31","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1743-6109.2008.00780.x","article-title":"Sexual function in well women: stratification by sexual satisfaction, hormone use, and menopause status","volume":"5","author":"Davison","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.clinthera.2017.08.021_bib32","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/jsm.12409","article-title":"Hormonal contraception and female pain, orgasm and sexual pleasure","volume":"11","author":"Smith","year":"2014","journal-title":"J Sex Med"},{"key":"10.1016\/j.clinthera.2017.08.021_bib33","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1007\/s11095-011-0648-6","article-title":"Population pharmacokinetic\/pharmacodynamic model for the sedative effects of flibanserin in healthy volunteers","volume":"29","author":"Troconiz","year":"2012","journal-title":"Pharm Res"},{"key":"10.1016\/j.clinthera.2017.08.021_bib34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/2160763X12459189","article-title":"Explaining some journal requirements","volume":"1","author":"Greenblatt","year":"2012","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2017.08.021_bib35","first-page":"S51","article-title":"Sample size determination for bioequivalence assessment by means of confidence intervals","volume":"30","author":"Diletti","year":"1992","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.clinthera.2017.08.021_bib36","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2174\/157015910792246254","article-title":"Antiepileptic drug interactions\u2014principles and clinical implications","volume":"8","author":"Johannessen","year":"2010","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.clinthera.2017.08.021_bib37","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/AOG.0000000000001286","article-title":"Sexual desire and hormonal contraception","volume":"127","author":"Boozalis","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clinthera.2017.08.021_bib38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1743-6109.2005.00198.x","article-title":"Impact of oral contraceptives on sex hormone-binding globulin and androgen levels: a retrospective study in women with sexual dysfunction","volume":"3","author":"Panzer","year":"2006","journal-title":"J Sex Med"},{"key":"10.1016\/j.clinthera.2017.08.021_bib39","first-page":"8","article-title":"20 ug versus >20 ug estrogen combined oral contraceptives for contraception","author":"Gallo","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2017.08.021_bib40","first-page":"3","article-title":"Anthropometric reference data for children and adults: United States, 2011-2014. National Center for Health Statistics","author":"Fryar","year":"2016","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.clinthera.2017.08.021_bib41","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2165\/11538900-000000000-00000","article-title":"Attitudes, awareness, compliance and preferences among hormonal contraception users: a global, cross-sectional, self-administered, online survey","volume":"30","author":"Hooper","year":"2010","journal-title":"Clin Drug Investig"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291817309426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291817309426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T10:07:00Z","timestamp":1535191620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291817309426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0149291817309426"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2017.08.021","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Flibanserin on the Pharmacokinetics of a Combined Ethinylestradiol\/Levonorgestrel Oral Contraceptive in Healthy Premenopausal Women: A Randomized Crossover Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2017.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}